Method for treatment of neuropathic pain

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S114000, C514S647000, C564S307000, C564S015000

Reexamination Certificate

active

08008286

ABSTRACT:
Compounds and methods useful for preventing and treating pain, e.g., neuropathic pain, in a subject in need thereof are provided. The compounds can be “S1P modulating” agents that are capable of inducing a detectable change in S1P receptor activity.

REFERENCES:
patent: 3153092 (1964-10-01), Burger
patent: 4939130 (1990-07-01), Jaeggi et al.
patent: 5405988 (1995-04-01), Klar et al.
patent: 6069251 (2000-05-01), Thurkauf et al.
patent: 6875757 (2005-04-01), Miller et al.
patent: 7060697 (2006-06-01), Marsilje et al.
patent: 7064217 (2006-06-01), Macdonald et al.
patent: 7241790 (2007-07-01), Lynch et al.
patent: 2004/0224941 (2004-11-01), Seko et al.
patent: 2005/0023386 (2005-02-01), Nishi et al.
patent: 2005/0032744 (2005-02-01), Michaelis et al.
patent: 2005/0222422 (2005-10-01), Lynch et al.
patent: 2006/0122181 (2006-06-01), Ikemoto et al.
patent: 2006/0135786 (2006-06-01), Saha et al.
patent: 2006/0211656 (2006-09-01), Albert et al.
patent: 2006/0223866 (2006-10-01), Evindar et al.
patent: 2007/0088002 (2007-04-01), Lynch et al.
patent: 2007/0191313 (2007-08-01), Beard et al.
patent: 2008/0249070 (2008-10-01), Lynch et al.
patent: 2009/0042955 (2009-02-01), Lynch et al.
patent: 2009/0105315 (2009-04-01), Lynch et al.
patent: 2009/0137531 (2009-05-01), Lynch et al.
patent: 2009/0253759 (2009-10-01), Lynch et al.
patent: 2009/0253760 (2009-10-01), Lynch et al.
patent: 2009/0253761 (2009-10-01), Lynch et al.
patent: 1 056 139 (1959-04-01), None
patent: 3 544 373 (1987-06-01), None
patent: 1 553 091 (2005-07-01), None
patent: 1 602 660 (2005-12-01), None
patent: 950388 (1964-02-01), None
patent: 1994 135935 (1994-05-01), None
patent: 1994 135936 (1994-05-01), None
patent: 2002 316985 (2002-10-01), None
patent: 2004 307442 (2004-04-01), None
patent: WO 99/35259 (1999-07-01), None
patent: WO 01/60819 (2001-08-01), None
patent: WO 01/71022 (2001-09-01), None
patent: WO 02/076995 (2002-10-01), None
patent: WO 02/092068 (2002-11-01), None
patent: WO 03/059880 (2003-07-01), None
patent: WO 03/061567 (2003-07-01), None
patent: WO2004/010987 (2004-02-01), None
patent: WO 2004010949 (2004-02-01), None
patent: WO 2004/017917 (2004-03-01), None
patent: WO 2004/024673 (2004-03-01), None
patent: WO 2004/028521 (2004-04-01), None
patent: WO 2004/047743 (2004-06-01), None
patent: WO 2004/096752 (2004-11-01), None
patent: WO 2004/096757 (2004-11-01), None
patent: WO 2004/103279 (2004-12-01), None
patent: WO 2004/103306 (2004-12-01), None
patent: WO 2005/032465 (2005-04-01), None
patent: WO 2005/118523 (2005-12-01), None
patent: WO 2006/001463 (2006-01-01), None
patent: WO 2006/020951 (2006-02-01), None
patent: WO 2007/085451 (2007-08-01), None
patent: WO 2007/086001 (2007-08-01), None
patent: WO 2007/091396 (2007-08-01), None
patent: WO 2009/023854 (2009-02-01), None
patent: WO 2009/043013 (2009-04-01), None
patent: WO 2009/146112 (2009-12-01), None
Dworkin et al. Advances in Neuropathic Pain, Diagnosis, Mechanism and Treatment Recommendations, Arch Neurol/vol. 60, Nov. 2003.
Schafer et al. Drug Discovery Today 2008, 13 (21/22), 913-916.
Horig et al. Journal of Translational Medicine 2004, 2(44).
Wolff, Burger's Medicinal Chemistry and Drug Discovery, Fifth Edition, vol. I: Principles and Practice, Wiley-Interscience 1995, pp. 974-977.
Sairam et al “Sildenafil in diabetic peripheral neuropathy”, Br. J. Diabetes Vasc. Dis 2002, vol. 2, pp. 304.
Kristina et al, “Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial”, BMJ, Jul. 2004, pp. 1-8.
International Search Report for PCT/US2007/002422.
Bandini, M. et al.,Eur. J. Chem.2001, 1937-1942.
Beilstein, Registry No. 6240345.
Bertus, P. et al.,Chem Commun, 2001, 1792-1793.
Brinkmann, V. et al.,Transplantation72, 2001, 764-769.
Brinkmann, V. et al.,J Biol Chem277, 2002, 21453-21457.
Burger, A. et al.,Journal of Medicine and Pharmaceutical Chemistry, vol. 4, No. 3, 1961.
Chiba, K. et al.,J Immunol160, 1998, 5037-5044.
Choi, D. et al.,J Med Chem39, 1996, 1907-1916.
Clair, T. et al.,Cancer Res63, 2003, 5446-5453.
Clemens, J. et al.,Bioorg Med Chem Lett(2003), 3401-3404.
Clemens, J. et al.,Bioorg.&Med. Chem. Lett.(2004), 4903-4906.
Clemens, J. et al.,Bioorg.&Med. Chem. Lett.(2005), 2005, 3568-3572.
Crosignani, S. et al.,Tetrahedron54, (1998), 15721-15730.
Davis, M. et al.,The J. of Bio. Chem., (2005), 9833-9841.
Dworkin, R. H. et al., Arch. Neurol., 60, 2003, p. 1524-1534.
Forrest, M. et al.,J Pharmacol Exp Ther309, 2004, 758-768.
Foss, F. et al.,Bioorganic&Medicinal Chemistry15, 2005, 4470-4474.
Foss, F. et al.,Bioorganic&Medicinal Chemistry15, 2007, 663-677.
Fujino, M. et al.,J Pharmacol Exp Ther305, 2003, 70-77.
Graler, M. H. et al.,FASEB18, 2004, 551-553.
Hale, Jeffrey J. et al.,Bioorganic&Medicinal Chemistry Letters14, 2004, 3351-3355.
Hale, J. J. et al., 2004Bioorg Med Chem Lett14, 2004, 3501-3505.
Hale, J. J. et al., (2004)Bioorg Med Chem Lett14, 3495-3499.
Hale, J. J. et al.,J Med Chem, 2004, 47, 6662-6665.
Hanessian, S. et al.,Bioorganic&Medicinal Chemistry Letters17, 2007, 491-494.
Hoshino, Y. et al., (1999)Transplant Proc31, 1224-1226.
Im, D. S. et al., (2000)J Biol Chem275, 14281-14286.
Im, D. S. et al.,Biochemistry40, 2001, 14053-14060.
Jones, L. et al., (1997)J Org Chem62, 1388-1410.
Kaiser, C. et al., XP009032189, Nov. 1962, 1243-1265.
Kawasaki, K. et al.,Tetrahedron, vol. 53, No. 18, 1997, 6337-6350.
Kharel, Y. et al.,J Bio Chem, vol. 280, No. 44, Nov. 4, 2005, 36865-36872.
Kimura, T. et al., (2003)Arterioscler Thromb Vasc Biol23, 1283-1288.
Kiuchi, M. et al.,(2000)J Med Chem43, 2946-2961.
Kon, J. et al., (1999)J Biol Chem274, 23940-23947.
Kotera et al. Chem. Abst.: Registry Record 19352-04-6.
Lee, M. J. et al., (1998)Science279, 1552-1555.
Lew, M. J. et al., “Analysis of competitive agonist-antagonist interactions by nonlinear regression”, (1995)Trends Pharmacol Sci16, 328-337.
Li, Z. et al.,Journal of Medicinal Chemistry, vol. 48, No. 20, Oct. 6, 2005, 6169-6173.
Maki, T. et al., (2002)Transplantation74, 1684-1686.
Maki, T. et al., (2005)Transplantation79, 1051-1055.
Mandala, S. et al., (2002)Science296, 346-349.
Matloubian, M. et al., (2004)Nature427, 355-360.
Sanchez, T. et al., (2003)J Biol Chem278, 47281-47290.
Sanna, M. G. et al., (2004)J Biol Chem279, 13839-13848.
Sanna, M. G. et al.,Nature Chemical Biology, vol. 2, Aug. 2006, 434-441.
Suzuki, S. et al., (1996)Transpl Immunol4, 252-255.
Van Brocklyn, J. R. et al., (1999)J Biol Chem274, 4626-4632.
Vogler, R. et al., (2005), No. 20, 2005, 6169-6173.
Xie, J. H. et al., (2003)J Immunol170, 3662-3670.
Yanagawa, Y. et al., (2000)Int J Immunopharmacol22, 597-602.
Yanagawa, Y. et al., (1999)Transplant Proc31, 1227-1229.
Yang, Z., et al., (2003)Clin Immunol107, 30-35.
Zhang, T. et al., (1997)Cancer Res57, 169-175.
Zhang, Y. H. et al.,J Neurophysiol96, 2006, 1042-1052.
Zhang, Y. H. et al.,J Physiol575.1, 2006, 101-113.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treatment of neuropathic pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment of neuropathic pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of neuropathic pain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2694868

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.